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BARNES, Corp, Loutit and Neal (1956), in a preliminary report, described the
successful eradication of murine leukaemia by treatment of leukaemia-bearing
mice with whole-body radiation followed by intravenous isologous bone marrow.
Attempts by us to cure a similar leukaemia in the same strain of mouse using
similar methods and a larger dose of radiation have not been successful. It
appeared that the prospects of eradicating leukaemia by this form of treatment
might be usefully explored by determining a survival curve for leukaemia cells
irradiated in vivo. Given data concerning the number of leukaemia cells in a
mouse at the time of treatment, such a curve would enable the chance of cure
by a specified dose of whole-body radiation to be predicted. This paper reports
the determination of a survival curve of this kind. We believe that the curve
will be of considerable general interest because we are not aware of a survival
curve for mammalian cells irradiated in vivo having been described previously.
An unsuccessful attempt to cure leukaemia-bearing mice by whole-body radiation
is analysed in the light of the data provided by this curve.
MATERIALS AND METHODS
Mice.-The CBA mice used in all the experiments were bred by brother-to-
sister mating in this laboratory and were aged 2-6 months when used for experi-
ment.
Leukaemia strain.-The lymphocytic type of leukaemia arose spontaneously
in a mouse ofthe same colony as that providing the mice used in the experiments,
and no evidence of a genetic difference between the malignant cells and the host
mice has been detected in a wide range ofexperiments which could have revealed
such a difference. A detailed account of the leukaemia, and of the method of
bioassay used to measure the number of viable leukaemia cells in a suspension,
appears elsewhere (Hewitt, 1958). Briefly, the method of bioassay is as follows:
a single-cell suspension ofleukaemia cells is prepared from the infiltrated liver of
a leukaemic mouse; the density of morphologically intact leukaemia cells is
determined by counting in a counting chamber under phase-contrast microscopy,
and accurate serial dilutions of the counted suspension are made; the mean
number ofleukaemia cells in 0-2 ml. volumes ofeach ofthe series ofdilute suspen-
sions is calculated from the cell density of the initial suspension and the dilution
factor; 0.2 ml. volumes ofeach ofa series ofselected dilutions are injected intra-
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group is recorded after a 90-day period of observation; from the results of the
assay the number of morphologically intact leukaemia cells required to convey
leukaemia to halfa group ofinjected mice (the TD50) is calculated by the method
of Reed and Muench (1938).
Irradiation.-To obtain data for the survival curve, individual mice were
exposed to whole-body irradiation by placing them in a perforated "Perspex"
cylinder closed at each end with a rubber bung, and positioning the cylinder in
a beam of 60Co gamma radiation from a Kilocurie beam unit (a "Theratron ").
The whole-body dose was delivered at a mean dose rate ofabout 80r/min. and was
given as equal exposures to both sides of the cylinder containing the mouse.
The distance from the source to the centre of the cylinder was 62 cm. and the
field size used was such as to cover the mouse very generously. Under these
conditions, the whole-body dose was uniform throughout the mouse to about
± 3 per cent. Single-cell suspensions of the leukaemia cells were prepared from
the livers of irradiated mice within 15 minutes of the end of irradiation and were
immediately bioassayed as described. The cells were kept at 0 to 2° C. from
the time of their removal from the irradiated mouse until their injection for
bioassay.
For the treatment ofgroups ofleukaemia-bearing mice, the mice were exposed
(in a " Perspex "-lined metal box carrying a " Perspex "lid), to 2400r 60Co gamma
whole-body irradiation delivered via a single field in a single dose over a period
of 22 hours. Under these irradiation conditions the whole-body dose was uniform
to about ± 5per cent. Within one hour ofthe end ofirradiation, eachoftheirradi-
ated mice received 106 nucleated isologous marrow cells intravenously.
EXPERIMENTS AND RESULTS
Results of Bioassay of leukaemia cellsfrom untreated leukaemic mice
Individual mice showing signs of illness 10-14 days after their injection with
leukaemia cells were sacrificed by fracture of the neck, and single-cell suspensions
of leukaemia cells were prepared from the infiltrated livers and bioassayed. In
6 separate experiments the TD50 values obtained were as shown in Table I.
It will be seen that no significant variation in the results of assay occurred over
a considerable period ofthe leukaemia's history, and that the age or sex ofthe mice
used for assay had no influence upon the end-point. The mean TD50 value for the
6 titrations, 2.0 cells, was used to signify the viability of cells from unirradiated
mice in the calculation ofsurvival rates to be described.
TABLE I.-TD50 Values obtained in 6 separate Bioassays of Leukaemia Cells
from Unirradiated Mice
Mice used for assay
Leukaernia , - Result of assay
passage No. Sex Age (days) (TD50)
42 . 96-183 . 12
49 . 98-128 . 3-0
54 . 145-172 . 0 7
58 . 9 141-158 . 2-0
63 . 184-195 . 3-0
70 . 358-424 . 2-1
Mean TD50 = 2.0 cells
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Results of bioassay of leukaemia cellsfrom irradiated mice
In separate experiments, individual mice at the same stage of the disease as
the untreated donor mice used above were exposed to prescribed total doses of
whole-body radiation. Within 10 minutes of the end of irradiation the mice were
sacrificed and single-cell suspensions of leukaemia cells were prepared from the
livers and bioassayed. The densities of morphologically intact leukaemia cells
in suspensions prepared from irradiated mice were not significantly different
from those in suspensions prepared from untreated mice. On the other hand,
the TD50 values obtained using cells from irradiated mice were found to be greater
than the mean (2.0 cells) of the TD50 values obtained for cells from untreated
mice and were a function of the dose of radiation. The survival rate in the
leukaemia cell population from an irradiated mouse was calculated as follows:
Mean TD50 for cells from untreated mice (i.e. 2.0)
TD50 for cells from irradiated mouse
e.g. TD50 for cells from mouse which received 900r = 500
2 ~.'~. Survival rate 500-0.004 103-6021 5OO
In a series of 6 separate experiments, the survival rates among cell populations
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FIG. 1.-Relationship between radiation dose and log survival rate among leukaemia cells
irradiated in vivo.
300 to 2000r were determined. The results of these experiments are given in
Table II. Fig. 1 shows the relationship between radiation dose and log survival
rate. Within the limits ofexperimental error, the relationship is linear. The line,
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drawn by inspection through the points, indicates that the Do value (mean lethal
dose of radiation, or dose required to reduce the viable cells to 37 per cent) is
about 162r for 6°0Co gamma radiation.
TABLE II.-Survival Rate of Liver Leukaemia Cells after Specified Doses of
Whole-body Radiation
Whole-body Fraction of cells Survival rate
radiation dose (r) TD50 surviving (log10)
300 . 8 . 0-25 . 1-4
600 . 76 . 0.026 . 242
900 . 500 . 0 004 3.6
1200 . 1930 0 001 . 3'02
1600 . 48,980 . 0-000041 . 5.-61
2000 . 95,500 . 0 000021 . g-32
At a later date, after the leukaemia strain had been taken through at least
12 further serial passages, two additional survival rates were determined at
each of the dose levels 800r, 1400r and 2000r. All six additional survival rates
were within 0.4 log of the rates predicted by the existing curve, which was thus
satisfactorily confirmed.
Attempted cure ofleukaemia-bearing mice by whole-body irradiation
Numerous unsuccessful attempts have been made to cure leukaemia-bearing
mice with whole-body radiation followed by intravenous isologous bone marrow.
In these, the following experimental conditions have been varied: size ofleukae-
mia cell inoculum, interval between injection of cells and treatment, and total
dose of whole-body radiation. The experiment to be described here combines the
mostfavourablelevelfor success ofeach ofthese conditions thathasbeenemployed
in the previous experiments. Five CBA mice were injected intraperitoneally
with a mean dose of 100 leukaemia cells. Seven to eight days after injection,
the mice were exposed to 2400r whole-body 60Co gamma radiation delivered in a
single dose given over a period of 22 hours at a uniform dose rate. Within one hour
of the end of irradiation the mice were injected intravenously with 106 isologous
nucleated marrow cells. All the treated mice died with obvious signs ofleukaemia
between 14 and 18 days after irradiation. Table III shows details of the experi-
ment including the treatment and fate of control groups. It will be seen that
TABLE III.-Fate of Leukaemia-bearing Mice Treated with 2400r Whole-body
Radiation and Bone Marrow, and of Various Control Mice
Survival time (days) Mice with
. ~ reticulocytes
After injection of After 10 days after
Treatment of mice Mortality leukaemia cells irradiation irradiation
Leukaemia cells only. 6/6 . 17-20 (mean, 18) - -
Radiation only . 6/6 . - 10-12 . 0/6
radiation + marrow . 1/6 . - (5) . 5/6
leukaemia + radiation
+ marrow . . 5/5 . 22-26 (mean, 24)* 14-18 . 5/5
* All these mice died with gross signs of leukaemia.
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although none of the treated leukaemic mice survived they all had circulating
reticulocytes 10 days after irradiation, indicating that the marrow grafts were
functioning, and their survival was prolonged by about 6 days compared with the
untreated control leukaemic mice. The implications of these results, considered
in the light ofthe survival curve described above, will be discussed later.
DISCUSSION
Doses ofradiation in the region ofthose used for determination ofthe survival
curve for in vivo radiation would not be expected to have an immediate lethal
effect on the leukaemia cells. This expectation has been fulfiled in our observation
that the yield ofmorphologically intact cells from the livers ofirradiatedleukaemic
mice is not significantly less than that obtained from untreated leukaemic mice.
The radiation-induced damage with which we are concerned here is damage
most probably to genetic material in the cell-which is manifested by the cells'
loss of reproductive integrity. The in vivo method we have used to detect cells
surviving the radiation confers a precise meaning upon the term "inactivation "
in the system we have used. "Inactivation" in our system means abolition
ofthe ability of a cell to give rise to an indefinitely large population ofdescendants
when transplanted to a healthy mouse of the same genotype as the leukaemia
cell strain. If we assume that inactivation of the cells is due to a direct effect
of radiation on the cells, and is not contributed to by cytotoxic constitutional
influences induced in the mice by whole-body radiation (and which might continue
to take a toll ofthe cells for many hours or days after the cessation ofirradiation)
then the data provided by our survival curve can be used to predict the chances
of eradicating leukaemia with a given dose of whole-body radiation. The addi-
tional information required for such prediction is an estimate ofthe total number
of leukaemia cells present in a mouse at the time ofirradiation.
The survival curve here reported applies to leukaemia cellsinfiltrating theliver.
Observations were confined to this organ because of the accuracy with which
malignant cell densities can be determined in suspensions prepared from it.
Single-cell suspensions prepared from such organs as the spleen contain greater
numbers of non-malignant single cells, derived from the normal tissue, and the
distinction of many of these normal cells from the leukaemia cells is not always
reliable using phase-contrast microscopy. If we assume that the radiosensitivity
ofthe liver leukaemia cells is representative ofthe total leukaemia cell population
in the leukaemic mouse, it can be seen from the extrapolated part of the curve
(Fig. 1) that approximately one in a million of the cells would be expected to
survive a dose of 2400r. Thus, at least one million leukaemia cells of radiosensi-
tivity comparable with that of those in the liver must have been present in the
leukaemia-bearing mice at the time they were not curable by 2400r. Such a
conclusion implies that the 100 cells injected intraperitoneally had given rise to
106 cells in the course of the 7 days elapsing between injection of the cells and
irradiation. If the 100 cells injected underwent continuous logarithmic increase
for 7 days, they would have to pass through about 13 generations in this time in
orderto reach a population of 106; their generation time would have to be about
13 hours. If it is assumed that the visible stages of mitosis occupy a period of
40 minutes, a population of cells undergoing reproduction with a generation
time of 13 hours would be expected to display a mitotic index ofabout 5 per cent.
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Mitotic indices at this level orhigher areregularly observed in histological
prepara-
tions of leukaemic livers. It can be concluded, therefore, that failure
to the
mice with 2400r whole-body radiation under the conditions described
is finding
which does not conflict with our data concerning the rate of cell reproduction
and the radiosensitivity of the cells as described by the survival curve (Fig. 1).
Barnes et al., (1956) succeeded in curing a high proportion of CBA
mice a
transplanted radiation-induced CBA leukaemia by exposing the mice to whole-
body radiation dose of 1500 rad 250kV X-rays delivered in 25 hours 7-8
days
after an inoculum of 106 leukaemia cells. The treated mice were injected
intra-
venouslywithisologous marrow soon afterradiation. For the purpose of comparing
the experiments of these workers with our own, we have multiplied
their 1500
rad 250 kV X-rays dose by the factor 1/0.95 to express it in roentgens and the
factor 1/0.75 to allow for the relative biological effectiveness (R.B.E.) of 60Co
gamma rays and 250 kV X-rays, making their dose equivalent in
biological
effectiveness to 2105r 60Co gamma rays. The factor we have applied to allow for
R.B.E. is we believe, the highest that available evidence permits. (M. R. C.
Unit, 1958).
It will be appreciated that the eradication of mouse leukaemia
by Barnes
et al., using an inoculum of 106 leukaemia cells and irradiating the mice 7days
later with a dose equivalent to 2105r60Co gamma rays, is in striking
contrast to
our failure to eradicate a very similar leukaemia in the same strain of mouse using
a dose of 2400r60Co gamma rays delivered at about the same dose rate and at the
same interval after the injection of only 102 cells. From our survival
curve (Fig.
1.) it is seen that a dose of 2105r is associated with a cell survival rate of1/105.4.
Thus, at this doselevel weshouldexpect some leukaemia cells to be surviving in
a mouse even intheunlikely event ofthe 106 cells ofthe inoculum having undergone
no increase during the period of 7 days following their injection.
Acomparisonofthebiologicalfeaturesofthe twoleukaemias revealed no strik-
ing differences, the celltype and manner ofdissemination being very similar. It
should bementioned, however, that theleukaemia ofBarnes et al. was radiation-
induced andtheirexperiments were done with material from the first few serial
passages (Loutit, 1957, personal communication), whereas our own experiments
were done with aleukaemia ofspontaneous origin which had undergone at least
60 serial passages.
Of the many hypotheses which can be advanced to explain the apparent
difference ofcurability between the two leukaemias, we consider that the most
probable, on the limited evidence available, is that which supposes that there
was some immunogenetic difference between the Barnes et al. leukaemia and
the host mice which were treated. Ifthis had been the case, the radiotherapy
couldhavetippedthebalanceinfavourofrecoveryofmicewhich were themselves
developing resistance. We base this conclusion upon the considerations which
follow. Firstly, in the Barnes et al. experiments two of the untreated control
mice which were injected with 106 leukaemia cells failed to develop leukaemia,
a finding which the authors themselves take to be evidence of "genetic drift"
in thehostmice. Secondly,repeated passage ofa tumour, such as our leukaemia
hadundergone, tends toreducetheinfluence ofslight immunogenetic incompati-
bilitybetweentumourandhosts. Finally, it canbe conjectured that a radiation-
inducedleukaemiais morelikelythan aspontaneous tumour to display a genetic
differencefromthehoststraininwhichitisinducedbecause it arises in an animal
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with its immunological resistance partly in abeyance, due to the whole-body
radiation, and because the original leukaemia cell induced may have acquired
antigenic modifications from chromosomal damage done by the radiation.
It has been argued that the whole-body radiation given to the mice for treat-
ment would have reduced theirimmunological resistance and thus the contribution
of that resistance to cure. However, whilst whole-body radiation inhibits the
institution ofimmunologicalresistance, itisknownnottoabolishexistingimmunity
(Clemmesen, 1938). The radiation used for treatment would not, therefore, be
expected to diminish such immunological resistance as the mice could have
acquired in the 7-day period between injection ofleukaemia cells and irradiation.
Cohen and Cohen (1954), after studying the influence of slight immunogenetic
incompatibility between tumour and host on the radiocurability of a C3H mam-
mary tumour concluded as follows: "It appears, therefore, that the radio-
sensitivity of a tumour is a quantitative measure of subliminal host-resistance
resulting from immunogenetic differences in the host-tumour relationship,
including extra-chromosomal factors ".
SUMMARY
Using a quantitative method for the transplantation of mouse leukaemia
cells within a closely inbred colony of CBA mice, it was found that an average of
2 cells was required to transplant leukaemia to half a group of injected mice
(i.e. TD50 = 2 cells). When cell suspensions were transplanted from donor mice
soon after their exposure to whole-body radiation, the TD50 was found to be
greater and to be a function of the radiation dose. From the data of several
experiments of this kind, using different doses of radiation, a radiation dose-log
cell survival rate curve was determined for the leukaemia cell population irradi-
ated in vivo. The implications of the curve, which was linear, did not conflict
with the results of experiments in which unsuccessful attempts were made to
cure leukaemia-bearing mice by their exposure to whole-body radiation followed
by the injection ofisologous bone marrow. The successful cure of a similar CBA
leukaemia by Barnes et al. (1956) using similar methods is discussed in relation to
data presented here.
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